Narrative review explores novel cardiac biomarkers and their role in prognosis and risk stratification in cardiovascular diseases, indicating potential advancements in diagnostics.
Key Points
Emerging biomarkers enhance early detection and prognosis of cardiovascular diseases, providing critical insights.
Traditional markers like troponin have limitations, emphasizing the need for novel cardiac biomarkers.
Integrating multiple biomarkers can improve diagnostic accuracy, leading to better risk stratification for patients.
Continued research is vital to validate the clinical utility of new biomarkers in routine cardiac care.